UniSa - IRIS Institutional Research Information System

MAROTTA, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.980
NA - Nord America 1.722
SA - Sud America 969
EU - Europa 772
Continente sconosciuto - Info sul continente non disponibili 81
AF - Africa 62
OC - Oceania 3
Totale 9.589
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 4.526
US - Stati Uniti d'America 1.534
BR - Brasile 727
IT - Italia 542
SG - Singapore 511
VN - Vietnam 458
CN - Cina 241
AR - Argentina 92
CA - Canada 61
FR - Francia 61
ID - Indonesia 53
BD - Bangladesh 46
EC - Ecuador 37
MX - Messico 36
IN - India 34
CO - Colombia 33
PY - Paraguay 33
GB - Regno Unito 25
DE - Germania 22
UA - Ucraina 19
RU - Federazione Russa 18
TR - Turchia 18
CL - Cile 17
IQ - Iraq 16
KR - Corea 16
CR - Costa Rica 15
ZA - Sudafrica 13
PL - Polonia 12
VE - Venezuela 12
JP - Giappone 11
MA - Marocco 11
PR - Porto Rico 11
EG - Egitto 10
GT - Guatemala 10
UY - Uruguay 10
HN - Honduras 9
KE - Kenya 9
ES - Italia 8
JM - Giamaica 8
NL - Olanda 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
IE - Irlanda 7
DO - Repubblica Dominicana 6
LT - Lituania 6
PE - Perù 6
AL - Albania 5
GP - Guadalupe 5
PH - Filippine 5
PK - Pakistan 5
UZ - Uzbekistan 5
AT - Austria 4
AZ - Azerbaigian 4
CW - ???statistics.table.value.countryCode.CW??? 4
MY - Malesia 4
NI - Nicaragua 4
RS - Serbia 4
SA - Arabia Saudita 4
SE - Svezia 4
DZ - Algeria 3
FI - Finlandia 3
GR - Grecia 3
IL - Israele 3
JO - Giordania 3
PA - Panama 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BO - Bolivia 2
BW - Botswana 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EE - Estonia 2
HR - Croazia 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
Totale 9.501
Salva come PNG Salva come JPEG
Città #
Hong Kong 4.519
San Jose 368
Milan 237
Singapore 181
Ho Chi Minh City 174
Dallas 150
Council Bluffs 142
Ashburn 114
Hanoi 104
Beijing 88
Rome 88
São Paulo 67
Santa Clara 57
Lauterbourg 52
Figino 46
New York 44
Rio de Janeiro 29
Los Angeles 28
Naples 27
Da Nang 25
Haiphong 25
Mexico City 19
Curitiba 17
Asunción 16
Boardman 16
Seoul 14
Thái Bình 14
Phoenix 13
Porto Alegre 13
Buffalo 12
Houston 12
Quito 12
Woodbridge 12
Brasília 11
Ribeirão Preto 11
San José 11
Toronto 11
Biên Hòa 10
Guayaquil 10
Ninh Bình 10
Salvador 10
Santo André 10
Tokyo 10
Buenos Aires 9
Chicago 9
Montreal 9
Phủ Lý 9
Santiago 9
Turin 9
Ann Arbor 8
Campinas 8
Guarulhos 8
Guatemala City 8
Medellín 8
Montevideo 8
Orem 8
Brooklyn 7
Cairo 7
Charlotte 7
Florence 7
Frankfurt am Main 7
Hortolândia 7
Jacksonville 7
Jakarta 7
Manaus 7
Memphis 7
Munich 7
San Juan 7
San Salvador 7
Baghdad 6
Belo Horizonte 6
Bắc Giang 6
Caxias do Sul 6
Chandler 6
Cuiabá 6
Hải Dương 6
Johannesburg 6
London 6
Maceió 6
Nairobi 6
North Bergen 6
Piracicaba 6
Recife 6
Seattle 6
Volta Redonda 6
Warsaw 6
Atlanta 5
Bắc Ninh 5
Canoas 5
Cincinnati 5
Coimbatore 5
Denver 5
Dublin 5
Izmir 5
Kyiv 5
Las Vegas 5
Nha Trang 5
Nuremberg 5
Philadelphia 5
Poplar 5
Totale 7.212
Salva come PNG Salva come JPEG
Nome #
Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer 740
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 511
The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. 413
The combined use of biological investigations, bio chromatographic and in silico methods to solve the puzzle of badge and its derivative's toxicity 341
Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy 339
Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer 337
Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight/obese patients 335
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: A comparative study 291
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present 288
Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules 273
Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge 237
BRAF V600E associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma 218
GH provocative tests stimulate the growth in children with idiopathic short stature 208
Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome 175
Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor Origins 169
Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life 163
TSH modulation in advanced differentiated thyroid cancer: a continuous walk on the tightrope between prognostic stratification, adverse events, and levothyroxine bioavailability 157
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm 150
Impact of Dietary Supplements on Clinical Outcomes and Quality of Life in Patients with Breast Cancer: A Systematic Review 147
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours 137
Fibrous Variant of Hashimoto’s Thyroiditis as a Diagnostic Pitfall in Thyroid Pathology 129
Editorial: Papillary thyroid cancer: prognostic factors and risk assessment 127
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1 125
Benign thyroid nodules with RAS mutation grow faster 118
Targeted therapy with kinase inhibitors in aggressive endocrine tumors 114
Papillary thyroid carcinoma with high percentage of BRAFV600E alleles have a higher recurrence rate 112
Fathoming the link between anthropogenic chemical contamination and thyroid cancer 109
Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management 108
Chromogranin a as circulating marker for diagnosis and management of neuroendocrine neoplasms: More flaws than fame 106
Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases 103
Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib 101
A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome 100
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 98
Are RET/PTC Rearrangements in Benign Thyroid Nodules of Biological Significance? 94
Total Thyroidectomy with Harmonic Scalpel Combined with Gelatin Thrombin Hemostatic: A Focus on the Elderly Population—A Multicentric Study 94
Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib (Endocrine, (2017), 57, 3, (539-543), 10.1007/s12020-016-1200-6) 93
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 93
Inibitori multichinasici nel trattamento del carcinoma differenziato tiroideo iodio-refrattario 91
Application of molecular biology of differentiated thyroid cancer for clinical prognostication 89
Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. 88
Role of nutritional therapy on dietary habits and glycemic control in insulin-treated kidney transplant patients with diabetes 85
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 84
Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application 84
Interferon-γ inhibits integrin-mediated extracellular signal-regulated kinase activation stimulated by fibronectin binding in thyroid cells 83
Radioiodide induces apoptosis in human thyroid tissue in culture 83
BRAF mutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma 81
Supplements in Oncology: Uses, Hurdles, Guidance, and Future Perspectives 80
Inhibition of Metalloproteinases-2, -9, and -14 Suppresses Papillary Thyroid Carcinoma Cell Migration and Invasion 80
BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto’s thyroiditis is a reliable assay 79
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint 77
Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas 75
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. 74
Growing thyroid nodules with benign histology and RET rearrangement 72
The evolving field of kinase inhibitors in thyroid cancer 71
Unintentional recurrent laryngeal nerve injuries following thyroidectomy: Is it the surgeon who pays the bill? 69
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 67
Interferon-γ inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells 65
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication 65
Germline polymorphisms of the VEGF pathway predict recurrence in nonadvanced differentiated thyroid cancer 64
High Growth Rate of Benign Thyroid Nodules Bearing RET/PTC Rearrangements 61
First-line lenvatinib and sorafenib in RR-DTC from a shared real-life context 61
Limitations of Chromogranin A in clinical practice 59
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 59
Hepatic arterial embolization in patients with neuroendocrine tumors 56
La diagnostica molecolare del nodulo tiroideo 43
Beyond the Genome: Can Epigenetics Forecast Therapeutic Success in Graves’ Disease and Thyroid Eye Disease? 22
Pathophysiology and treatment of exercise-associated hyponatremia 17
Somatic genomic profiling reveals clinically relevant heterogeneity in RAS-mutant sporadic medullary thyroid carcinoma 17
Modulation of chemokine secretion and oxidative stress in vitro in thyroid cells after exposure to thiocyanate, nitrate, or perchlorate 11
Precision Thyroid Oncology Using Genetic-Based Therapies: A Narrative Review 10
Stage-specific quality of life and tolerability of CDK4/6 inhibitors in HR-positive/HER2-negative breast cancer: a narrative review 8
Network based approach identifies miR-145-3p as a central regulatory hub associated to the progression from localized to metastatic medullary thyroid carcinoma 6
Totale 9.589
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.892
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.892
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226 0 0 0 0 0 0 0 0 1 1 1 3
2022/202312 1 0 0 1 2 4 0 0 4 0 0 0
2023/20246 2 0 0 0 0 1 0 0 0 1 0 2
2024/20258 0 0 0 2 1 1 1 1 1 0 0 1
2025/20268.535 586 2.769 2.215 1.004 335 101 259 203 193 402 124 344
2026/2027981 93 193 279 416 0 0 0 0 0 0 0 0
Totale 9.589